A Feasibility Trail of Proton Radiation Therapy or Intensity Modulated Radiation Therapy (IMRT) Using Mild Hypofractionation for Intermediate -Risk Adenocarcinoma of the Prostate
This study will be done in two phases, first, a feasibility study and then a registration
study. In the first, feasibility will be established using the primary objectives set
below. The second phase will begin no earlier than 30 days after the last patient in the
initial phase has completed treatment and once safety and feasibility has been verified.
The secondary objectives will serve as the objectives for the second phase of the study.
Observational Model: Cohort, Time Perspective: Prospective
Number of Participants with Adverse Events
Unable to tolerate 10% of treatments using proton radiotherapy. Unable to complete all treatments. Cannot be given treatment because anatomy is such that a dosimetrically satisfactory treatment plan cannot be devised.
Within 10 days
Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
United States: Institutional Review Board
|Abramson Cancer Center of the University of Pennsylvania||Philadelphia, Pennsylvania 19104-4283|